Breaking Medical News and In Depth Medical Stories

 
Search News:
     
PROGRAMS
 
 
Study examines outcomes of ranibizumab for AMD after 4 years
Study examines outcomes of ranibizumab for AMD after 4 years (July 9, 2013 - Insidermedicine) From Denmark - A new report published in Ophthalmology examines the outcomes of ranibizumab treatment after 4 years. Researchers studied 600 eyes of 555 age-related macular degeneration patients, all of whom were treated with intravitreal injections of ranibizumab. Patients were followed from 2007 to 2011. Results showed that one third of the eyes were still receiving treatment after 4 years, and had stable visual acuity.
 
OUR TEAM
More...  
EDITORIAL BOARD
More...